comparemela.com
Home
Live Updates
Dr Aldoss on the Mechanism of Action of Ponatinib in Ph+ ALL : comparemela.com
Dr Aldoss on the Mechanism of Action of Ponatinib in Ph+ ALL
Ibrahim Aldoss, MD, discusses the use of ponatinib as evaluated in the PhALLCON trial for patients with Ph+ ALL.
Related Keywords
Philadelphia ,
Pennsylvania ,
United States ,
Ibrahim Aldoss ,
Hematology Tissue Bank ,
Division Of Leukemia ,
Leukemia Research ,
Department Of Hematology ,
Gehr Family Center ,
Hematopoietic Cell Transplantation ,
Leukemia Registry ,
Hematologic Oncology ,
Onclive Tv ,
City Of Hope ,
comparemela.com © 2020. All Rights Reserved.